@venturebeat.com 6 years ago
Augmenix Announces First Prostate Cancer Patients Treated with SpaceOAR® Hydrogel in Israel
@venturebeat.com 6 years ago
Augmenix Announces First Prostate Cancer Patient Treated with SpaceOAR® Hydrogel in New Zealand
@venturebeat.com 6 years ago
Augmenix Announces First Prostate Cancer Patient Treated with SpaceOAR® Hydrogel in Canada
@venturebeat.com 7 years ago
Phase 3 Trial Data Show Use of SpaceOAR® Hydrogel Helps Maintain Erectile Function Following Prostate Cancer Radiation Treatment
@venturebeat.com 7 years ago
Augmenix Announces Positive Three-Year Long-Term Data Highlighting Benefits of SpaceOAR® Hydrogel Spacer for Patients with Prostate Cancer